The Patent Finder

Naphthyridine Derivatives as Inhibitors of Hypoxia Inducible Factor (HIF) Hydroxylase

Kyntra Bio, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 3 of these applications claim priority to application PCT/US2012/023546, filed Feb 1, 2012. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 8,921,389Naphthyridine Derivatives as Inhibitors of Hypoxia Inducible Factor (HIF) Hydroxylase
In force
 · High confidence
UsedRemaining
Kyntra Bio, Inc.In forceHigh confidence
US 9,271,970Naphthyridine Derivatives as Inhibitors of Hypoxia Inducible Factor (HIF) Hydroxylase
In force
 · High confidence
Kyntra Bio, Inc.In forceHigh confidence
US 9,695,170Naphthyridine Derivatives as Inhibitors of Hypoxia Inducible Factor (HIF) Hydroxylase
In force
 · High confidence
Kyntra Bio, Inc.In forceHigh confidence
3 of 3 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited